Hematopoiesis is the cumulative result of intricately regulated signal transduction cascades that are mediated by cytokines and their cognate receptors. Proper culmination of these diverse signaling pathways forms the basis for an orderly generation of dierent cell types and aberrations in these pathways is an underlying cause for diseases such as cancer. Over the past several years, downstream events initiated upon cytokine/ growth factor stimulation have been a major focus of biomedical research. As a result, several key concepts have emerged allowing a better understanding of the complex signaling processes. A group of novel transcription factors, termed signal transducers and activators of transcription (STATs) appear to orchestrate the downstream events propagated by cytokine/growth factor interactions with their cognate receptors. Until recently, the JAK proteins were considered to be the tyrosine kinases, which dictated the levels of phosphorylation and activation of STAT proteins, forming the basis of the JAK-STAT model. However, over the past few years, increasing evidence has accumulated which indicates that at least some of the STAT protein activation may be mediated by members of the Src gene family following cytokine/growth factor stimulation. Studies have demonstrated that the Src-family of tyrosine kinases can phosphorylate and activate certain STAT proteins, in lieu of JAK kinases. In such a scenario, JAK kinases may be more crucial to phosphorylation of the cytokine/growth factor receptors and in the process create docking sites on the receptors for binding of SH2-containing proteins such as STATs, Src-kinases and other signaling intermediates. Tyrosine phosphorylation and activation of STAT proteins can be achieved either by JAKs or Src-kinases depending on the nature of STAT that is being activated. This forms the basis for the JAK-Src-STAT model proposed in this review. The concerted action of JAK kinases, members of the Src-kinase family and STAT proteins, leads to cell proliferation and cell survival, the end-point of the cytokine/growth factor stimulus.
Hematopoiesis, the process of generation of blood cells, is a constant continuum in development since most mature blood cells are short-lived and must be replaced throughout adult life. Blood cells originate from a self-renewing population of multi-potential hematopoietic stem cells that become committed to dierentiate along the erythroid, megakaryocytic, granulocytic, monocytic and lymphocytic lineages. It has been largely acknowledged that this process is achieved through an intricate network of complex but ®nely tuned regulatory pathways (Paulson and Bernstein, 1995; Zon, 1995) . However, the precise mechanisms involved in achieving the coordinated production of dierent types of blood cells as well as regulation of critical events of dierentiation commitment and cellular maturation are still vague. Over the past several years, it has become increasingly clear that hematopoietic cell proliferation and dierentiation is controlled by a family of soluble polypeptides referred to as cytokines which include the interleukins, interferons, colony-stimulating factors and erythropoietin (Metcalf, 1989; Kishimoto et al., 1994) .
Advances in hematopoietic cell culture have allowed the expansion of certain populations of hematopoietic cells in the presence of cytokines and the availability of these cell lines has allowed in vitro investigations on the mechanisms by which these cytokines direct signal transduction in the hematopoietic cell. Some of these cell lines display dramatic morphological changes, which occur during maturation of hematopoietic cells in response to colony stimulating factors. A commitment process can be observed in established myeloid cell lines. During cell division these cells have the option of self-renewal, that is replication without commitment, or irreversible commitment to the formation of dierentiation progeny. Self renewal can be suppressed and dierentiation commitment can be induced in such cell lines by more than one cytokine: for example, leukemia inhibitory factor (LIF) or interleukin-6 induce dierentiation in M1 cells (Lord et al., 1991; Selvakumaran et al., 1992) . Similarly, the interleukin-3-dependent murine myeloid cell line 32Dcl3 can be induced to undergo dierentiation to either granulocytes or macrophages depending upon the stimulus provided. Incubation of the 32Dcl3 cells with the granulocyte colony stimulating factor (G-CSF), results in the dierentiation of 32Dcl3 cells to neutrophilic granulocytes and exposure of these cells to granulocyte-macrophage colony stimulating factor (GM-CSF) results in dierentiation to macrophages Kreider et al., 1990; Rovera et al., 1987; Migliaccio et al., 1989) . Utilization of these cell lines as model systems to investigate the signal transduction pathways initiated by these cytokines and CSFs has resulted in a better understanding of Oncogene (2000) 19, 2532 ± 2547 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc *Correspondence: EP Reddy the players involved in hematopoietic cell development. Moreover, molecular cloning of the cDNAs and puri®cation of several of these cytokines has further aided in a more precise de®nition of their structural features and mechanism of action. This information has opened the door for testing their clinical value in immunological, hematological and malignant disease.
Cytokines and cytokine receptors
Hematopoietic cell growth and dierentiation is mediated by a group of soluble factors known as cytokines Hunter, 1993; Stahl and Yancopoulos, 1993; Taniguchi, 1995) . These molecules bind to their cognate receptors and mediate intracellular signal transduction events that result in the modulation of gene expression. One of the characteristic features of cytokines is their functional pleiotropy, i.e. a particular cytokine can exhibit a wide variety of biological functions on various tissues and cells. Interleukin-6 (IL-6) is a typical example of such a multifunctional cytokine. IL-6 exerts its eects not only on the B-cell maturation process but also on T cells, hepatocytes, hematopoietic progenitor cells and neuronal cells (Kishimoto, 1989; Kishimoto et al., 1992; Akira et al., 1993) . Cytokines also function in a redundant manner and several dierent cytokines can exert similar and overlapping functions on the same cell type. For example, in addition to IL-6, other cytokines such as IL-2, IL-4, IL-5 and interferon-g can induce antibody production in B cells (Kishimoto, 1989) . Also, two pleiotropic cytokines, IL-6 and leukemia inhibitory factor (LIF) can induce dierentiation of the murine myeloid cell line M1 into macrophages (Selvakumaran et al., 1992) . Such functional pleiotropy and redundancy, initially thought to be a consequence of the structural characteristics of the cytokines themselves, is now regarded to be a re¯ection of similarities and dierences in the proteins interacting with cytokine receptors. The overlapping nature of the downstream signaling proteins recruited by the receptors to elicit the cytokine stimulus account for the functional pleiotropy and redundancy of cytokines. Most cytokine receptors consist of a multisubunit protein complex: a unique and speci®c ligand binding subunit, and a signal transducing subunit, which may be structurally similar to other members of the cytokine receptor superfamily Hunter, 1993; Stahl and Yancopoulos, 1993; Taniguchi, 1995) . The signal transducing subunit can be regarded as the`work-horse' of the cytokine receptor complex. Not only does it receive signals initiated upon cytokine binding, but it is also responsible for propagation of the signals to downstream target proteins. The signal transducing subunit recruits cytoplasmic proteins, which results in changes in protein-protein interactions as well as changes in the phosphorylation status of certain proteins.
Cytokine receptors share a typical structure consisting of about 210 amino acids in their extracellular domain. These proteins have conserved motifs containing cysteine (C) and tryptophan (W) residues in their N-terminal portion. A typical sequence of tryptophan-serine-Xtryptophan-serine (W-S-X-W-S), where X refers to any non-conserved amino acid residue, is present in the Cterminus . Structurally, this region is also composed of two ®bronectin type III modules. A hinge region connects these two modules, each of which comprises of approximately 100 amino acids. The hinge region, which also houses the W-S-X-W-S motif, is predicted to function as a ligand interaction site. Sitedirected mutational analysis within the hinge region, particularly the W-S-X-W-S motif abolishes or greatly reduces the ligand binding capacity of the receptors (Barry et al., 1997) .
The cytokine receptor family has been sub-divided based on the characteristic structural motifs in their extracellular domains Hunter, 1993; Stahl and Yancopoulos, 1993; Taniguchi, 1995) . The main sub-types of this large family are (i) the gp130 family, (ii) the IL-2 receptor family, (iii) the growth hormone (GH) family, (iv) the interferon (IFN) family and (v) the gp140 family (Figure 1) . While a detailed description of the features of each of these families is beyond the scope of this review, we describe a few salient features of these protein families. For detailed information on the cytokine receptor families, readers are referred to several expert reviews on the topic Hunter, 1993; Stahl and Yancopoulos, 1993; Taniguchi, 1995) .
The gp130 family
Receptors for IL-6, IL-11, cardiotropin-1 (CT), ciliary neurotrophic factor (CNTF), oncostatin M, leukemia inhibitory factor (LIF), all signal through a common bchain called gp130. Apart from this common gp130 signal transducing subunit, each of the above mentioned receptors possess a unique and speci®c ligand binding a-subunit.
IL-2 receptor family
The IL-2 receptor consists of three subunits, a, b and g, of which the gamma chain (IL-2Rg chain) is shared by receptors for the IL-4, IL-7, IL-9 and IL-15. Each of these receptors, like the IL-2 receptor, consist of three subunits, termed a, b and g. Of these, the a subunit acts as the ligand binding subunit, while the b and g subunits function as signal transducing subunits. The IL-2Rg chain associates with JAK3 and mutations in both IL-2Rg chain and JAK 3 results in a nonfunctional receptor, which abrogates signaling via IL-2, IL-7, IL-9 and IL-15 (Russell et al., 1994 (Russell et al., , 1995 .
The growth hormone (GH) family
This family includes receptors for growth hormone (GH), prolactin, erythropoietin, GCSF and thrombopoietin. These receptors consist of a single subunit that forms homodimers upon ligand binding. While being structurally similar, they do not cross react with ligands of each other and transduce signals which are speci®c for a cytokine.
The interferon (IFN) family
This family comprises of the IFN alpha receptor (IFNAR), the IFN gamma receptor (IFNGR) and the IL-10 receptor. The IFN gamma receptor also has two chains, IFNGR1 and IFNGR2. The IL-10 receptor comprises of two chains, IL-10R1 and IL-10R2. In the case of these receptors, both subunits function as signal transducing components of the receptor and bind to downstream signaling proteins such as JAKS and STATs.
The gp140 family
This family includes the receptors for cytokines, IL-3, IL-5 and GM-CSF. The IL-3 and GM-CSF genes located on the 5q region of chromosome 5 has been associated with hematopoietic malignancies, underlining the importance of these cytokines in hematopoietic signaling (Blalock et al., 1999) . The receptors for these cytokines have unique ligand binding-alpha chains and share the common beta (gp140) signal transducing subunit (Itoh et al., 1990; Murata et al., 1992; Gearing et al., 1989; Hayashida et al., 1990) . In this review, we will examine in detail, the signal transduction mediated by IL-3, via its speci®c receptor, the IL-3R. Comprehensive reviews on the structure-function analysis of the gp140 receptor proteins, IL-3R, IL-5R and GM-CSFR, have been recently published (Bagley et al., 1997; de Groot et al., 1998; Woodcock et al., 1999) .
Interleukin-3 (IL-3) and its receptor (IL3-R)
Interleukin-3 (IL-3), also referred to as multi-lineagecolony stimulating factor (Multi-CSF), is a 20 ± 26 kDa product of CD4 + T cells that acts on the most immature marrow progenitors (Ihle et al., 1983; Metcalf, 1989; Pierce et al., 1989) . IL-3 is capable of inducing the growth and dierentiation of multipotential hematopoietic stem cells, neutrophils, eosinophils, megakaryocytes, macrophages, lymphoid and erythroid cells. IL-3 has been used to support the proliferation of murine cell lines with properties of multi-potential progenitors, immature myeloid as well as T and pre-B lymphoid cells.
The IL-3 receptor (IL-3R) is composed of an asubunit of 60 ± 70 kDa and a b-subunit of 130 ± 140 kDa (Figure 2 ; Miyajima et al., 1992) . Both subunits contain the extracellular conserved motifs found in the cytokine receptor superfamily. The cytoplasmic domains share limited similarity with other cytokine receptors and lack detectable catalytic domains such as the tyrosine kinase domains. However, evidence suggests that IL-3 signal transduction involves Figure 1 Growth factor and cytokine receptor families. Growth factor and cytokine receptors can be classi®ed into the following subfamilies: (i) The protein tyrosine kinase (PTK) receptors, (ii) gp130 family, (iii) IL-2 receptor family, (iv) growth hormone (GH) receptor family, (v) interferon (IFN) receptor family, (vi) gp140 family. All receptors possess extracellular ligand binding domains and an intracellular signal transduction domain. PTK receptor family members harbor tyrosine kinase domains that catalyze the transfer of phosphate group to downstream substrates. These receptors also allow protein-protein interactions via other structural motifs like the SH2 and SH3 domains. The non-PTK family members recruit cellular tyrosine kinases to mediate their signal transduction pathways IL-3 signaling and JAK-Src-STAT pathway EP Reddy et al tyrosine phosphorylation. Recent structure/function studies using the common b-chain of IL-3, GMCSF and IL-5 have shown that the cytoplasmic domain of this chain can be divided into two distinctive functional domains (Bagley et al., 1997; Woodcock et al., 1999) . The membrane proximal intracellular portion of the receptor till amino-acid number 589, that includes the Box 1 region, was shown to be necessary and sucient for DNA synthesis mediated by several of these cytokines including IL-3 (Sato et al., 1993; Tian et al., 1996) . This region was also found to be required for the induction of proliferation-associated genes such as c-myc, pim-1 and oncostatin M. Following cytokineinduced hetero-dimerization, this region of the receptor was found to bind to multiple signal-transducing proteins, which include JAKs, STATs, c-Src, phosphotidylinositol-3 kinase as well as Vav (Quelle et al., 1994; Jaster et al., 1997; Yoshimura et al., 1995 Yoshimura et al., , 1998 Rao and Mufson, 1995; Matsuguchi et al., 1995) . The membrane distal domain of the receptor, spanning amino acids 589 ± 881, was shown to be required for growth inhibition that can be induced by some of the cytokines. More importantly, this region appears to be necessary for the promotion of viability of hematopoietic cells . This region was also found to interact with multiple signal-transducing proteins such as Shc and SHP and mediate transcriptional activation of c-fos and c-jun as well mediate the activation of c-Raf and p70S6K. The common beta subunit (b c ) of the IL-3 receptor is shared by the receptors for IL-5 and GM-CSF. In mice, an additional IL-3 speci®c-b c subunit (b ) exists, which is used in preference to the b c subunit for IL-3 signal transduction (Nicola et al., 1996) . Functionally, the b c subunit of the IL-3, IL-5 and GM-CSF receptors is analogous to gp130, the common signal transducing subunit shared by receptors for IL-6, CT, CNTF, oncostatin M, LIF and IL-11 and to the IL-2Rg chain which is shared by receptors for IL-2, IL-4, IL-7, IL-9 and IL-15. The common b c subunit of the IL-3R, similar to all the other common subunits, executes two crucial functions following IL-3 binding. It promotes the initial ligand-receptor (IL3-IL3R) binding from a low anity to a high-anity interaction and later operates as the major signal transducing component.
The genes for both the b c subunit and b IL-3 are localized to chromosome 15 in mouse and chromosome 22 in humans Gorman et al., 1992; Shen et al., 1992; Kremer et al., 1993) . Functional importance of the common b c subunit has been investigated by gene-targeting approaches. b cde®cient mice fail to respond to GM-CSF and IL-15, while retaining the ability to respond to IL-3 stimulation, probably due to compensation by b IL-3 (Robb et al., 1995; Nishinakamura et al., 1995) . b c de®cient mice exhibit normal numbers of hematopoietic stem cells and progenitor cells within the bone marrow with a de®nite reduction in the numbers of eosinophils (Robb et al., 1995; Nishinakamura et al., 1995) . To investigate the eects of IL-3, IL-5 and GM-CSF, compound knockout mice lacking both the b c subunit and IL-3 genes have been developed (Nishinakamura et al., 1996) . These mice lacked a functional IL-3 cytokine and functional receptors for IL-3, IL-5 and GM-CSF, due to a lack of the b c subunit. Surprisingly, these mice had a phenotype which resembled a phenotype similar to the b c subunitde®cient mice (Robb et al., 1995; Nishinakamura et al., 1995) . These results indicated that, at least in mice, the functions of IL-3, IL-5 and GM-CSF in hematopoiesis could be compensated for by other cytokines. That the b c subunit is involved in ligand interactions, is con®rmed by studies on the IL-3, IL-5 and GM-CSF ligands (Hercus et al., 1994a,b; Shanafelt et al., 1992; Barry et al., 1994; Tavernier et al., 1995) . Amino acid substitutions involving a conserved glutamine residue in the ®rst alpha helix of the IL-3, IL-5 and GM-CSF receptors abolishes high-anity binding. This mutation, however, does not aect the abilities of the mutated cytokines to bind to their respective alpha chains.
The a chains of IL-3, GM-CSF and IL-5 have dierent structures but all of them contain an extracellular ligandbinding domain, a transmembrane domain and an intracellular domain. Apart from ligand-binding function, these chains appear to also perform additional functions in signal transduction. Thus, the a-chain of IL-3R was shown to be necessary for the activation of STAT-5 (Matsuda and Hirano, 1994; Doyle and Gasson, 1998) . This region was found to mediate transcriptional activation of c-fos and c-jun and also mediate the activation of c-Raf and p70S6K (Itoh et al., 1996; Tian et al., 1996; Watanabe et al., 1995) .
The a and b c chains of the IL-3 receptor are not associated in the absence of the ligand. The presence of ligand induces a and b c chain association to form a heterodimeric complex (Orban et al., 1999) . This process which constitutes high-anity binding and optimal receptor activation, requires the formation of disulphide bonds between the a and b c chains which allows receptor heterodimerization. Two contiguous amino acid residues on human IL-3, aspartic acid 21 (D21) and glutamic acid 22 (E22), conserved in the IL-3, IL-5 and GM-CSF cytokines, interact with the IL-3 receptor a and b c chains and are crucial for IL-3 activity (Barry et al., 1994) . Receptor activation is followed by activation of receptor associated JAK2 kinase and tyrosine and serine phosphorylation of the b c chain cytoplasmic tail (Quelle et al., 1994; Stomski et al., 1999) . Recent data indicate that heterodimerization of the a and b c chains of the IL-3R is necessary and sucient for IL-3 induced mitogenesis (Orban et al., 1999) . In this study, the authors generated chimeric IL-3 receptor molecules with extracellular domains derived from the cell surface molecules, CD8 or CD16. These cell surface molecules were chosen since they represent proteins non-related to members of the cytokine receptor family. The chimeras were transfected into Ba/F3 or CTLL-2 cells, upon which it was observed that mitogenic signals were generated only subsequent to heterodimerization of the cytoplasmic domains of a and b c subunits of the IL-3R. Furthermore, homodimers of a and b c chains, alone or in combination, were unable to sustain a mitogenic response. The formation of the a and b c chain heterodimers, which resulted in an active IL-3R, also correlated with tyrosine phosphorylation of JAK2.
The role of IL-3 in the promotion of hematopoietic progenitor cell survival and proliferation is well documented. However, the role of IL-3 in dierentiation of hematopoietic cells is not very clear. In a recent study, Evans and co-workers demonstrated that activation of two gp140 receptor family members, the IL-3R and GM-CSFR, in a multipotential hematopoietic progenitor cell line, resulted in dierentiation of cells in response to IL-3 (Evans et al., 1999) . In this study, murine FDCP cells, which have the potential for self-renewal or dierentiation, were transfected with chimeric receptor subunits consisting of the extracellular domain of the IL-3Ra and the intracellular domain of the GM-CSFRa subunit. This chimeric receptor promoted dierentiation in response to IL-3, elucidating the role of the a subunit in conferring speci®city and determining cell fate via distinct signal transduction events. For a detailed characterization of regions on the a and b c chains responsible for interaction with other signal transduction molecules, regulation of gene expression, DNA synthesis, proliferation, dierentiation and apoptosis, readers are referred to a recent review on the topic and references therein (Blalock et al., 1999) .
IL-3-induced signal transduction pathways
The signaling via the IL-3/GM-CSF and IL-5 receptors is achieved by recruitment of multiple signal transduction cascades that are represented by members of distinct protein families ( Figures 3, 4 and 5). The concerted action of members of these protein families, functionally classi®ed as (i) tyrosine or serine/threonine kinases, (ii) adaptor or docking proteins, (iii) transcription factors, (iv) pro-or anti-apoptotic proteins, culminates in the growth and survival phenotype propagated by these cytokines. We describe brie¯y the signal transduction intermediates that convey the growth and cell survival responses mediated by IL-3.
STAT signaling pathways
The family of cytoplasmic protein tyrosine kinases, Janus Kinases or JAKs, appear to be the pivotal mediators of cytokine signaling pathways Taniguchi, 1995; Ihle et al., 1995; Schindler and Darnell, 1995; Ihle, 1995) . The JAKs were initially identi®ed by polymerase chain reaction-based strategies as well as low stringency hybridization techniques (Wilks, 1989) . Currently, the JAK-kinase family is comprised of four members: TYK2, JAK1, JAK2 and JAK3. The unique structure of the JAK kinases clearly distinguishes them from other members of the protein tyrosine kinase family. The most intriguing feature is the absence of any Src homology 2 (SH2) or Src homology 3 (SH3) domains and the presence of two domains with extensive homology to the catalytic domains of tyrosine kinases. The structural domains of the JAK kinase family are referred to as the JAK homology regions (JH1-JH7), where JH1 is the protein tyrosine kinase domain, JH2 refers to the pseudokinase domain and JH3-JH7 are other blocks of conserved sequence residues characteristic to members of the JAK family. The precise functions of the JH3-JH7 domains as well as the pseudokinase domain are at present unclear. The kinase-like JH2 domain, despite harboring most of the conserved amino acid residues characteristic of the kinase domain, lacks any observable tyrosine kinase activity. It is now clear that this kinase-like domain plays a regulatory role (Luo et al., 1997) . The sequences that are amino terminal to the kinase and kinase-like domains bear no resemblance to any characterized protein motif. Considering the variety of interactions and functions performed by the JAK kinase family members it seemed plausible that these domains may be responsible for some key interactions with other proteins, which could act as their substrates. Recent studies indicate that the amino terminal regions are also involved in receptor binding (Gauzzi et al., 1997; Chen et al., 1997) .
IL-3/IL-5/GMCSF activation of hematopoietic cells appears to result predominantly in the activation of JAK-2, although JAK-1 and TYK-2 have also been found to be activated in certain cell systems Quelle et al., 1994; Lutticken et al., 1994; Chaturvedi et al., 1997 Chaturvedi et al., , 1998 Jaster et al., 1997) . The membrane proximal region of the IL-3R b c chain is involved in association with the N-terminal region of JAK2. Deletion of this region of the IL-3R b c chain results in loss of activation of JAK2 (Quelle et al., 1994) . In addition, the cytoplasmic portion of the achains of IL-3, GM-CSF and IL-5 receptors also appear to be involved in the activation of JAK2 kinase (Quelle et al., 1994; Cornelis et al., 1995; Kouro et al., 1996; Matsuguchi et al., 1997; . Activation of JAK2 leads to phosphorylation of the IL-3R b c chain on multiple tyrosine residues (Y577, Y612, Y695 and Y750) which in turn serve as docking sites for other signal transducing proteins, the most important of which are the STATs Inhorn et al., 1995; van Dijk et al., 1997; Pazdrak et al., 1995; Chin et al., 1996; Woodcock et al., 1996) . IL-3 activation of hematopoietic cells appears to lead to the activation of multiple STATs, which include STAT-1, STAT-3, STAT-5 and STAT-6. The nature of STATs that are activated appear to be more dependent of the cell line that is used in the study, rather than the cytokine or the nature of JAK activated by cytokine/ receptor interactions. This observation suggests that Figure 3 The JAK-STAT signal transduction pathway. According to this model, interaction of IL-3 with its receptor leads to the activation of JAKs, which phosphorylate the receptor and these phosphorylated tyrosines serve as docking sites for STATs. STATs are then phosphorylated by JAKs, which results in their dissociation from the receptor, dimerization and translocation to the nucleus where they activate gene transcription Oncogene IL-3 signaling and JAK-Src-STAT pathway EP Reddy et al neither the cytokine receptors nor the JAKs by themselves dictate the nature of the STATs that are activated by a given cytokine. It is also interesting to note that a C-terminal deletion mutant of b c , termed bc541 was found to be de®cient in its ability to activate STAT-5, while still being able to activate JAK2 (Smith et al., 1997) . These observations also imply that while JAK2 activation is a critical step in IL3/IL5/GMCSFmediated activation of their cognate receptors, it is by itself not adequate for STAT activation.
The signal transducers and activators of transcription Over the past few years researchers have deciphered a signaling pathway which initiates within the cytoplasm but quickly translocates to the nucleus to activate transcription of target genes. This novel signaling pathway features a group of transcription factors named as STATs or Signal Transducers and Activators of Transcription Darnell, 1997) . These transcription factors were originally described by Darnell and his co-workers (Darnell et al., 1994; Darnell, 1997) as ligand-induced transcription factors in interferon-treated cells. Subsequent studies by a number of groups showed that STATs play a critical role in signal transduction pathways associated with several cytokines and neurokines including the interleukins, the interferons, erythropoietin, prolactin, growth hormone, oncostatin M (OSM), and ciliary neurotrophic factor (CNTF) (reviewed by Darnell, 1997) . To date, six mammalian genes that code for dierent STATs have been identi®ed, all of which encode for proteins of 750 ± Figure 4 The Ras-MAP kinase pathway. Src-tyrosine kinases also signal via the ras-raf-MAP kinase signaling cascade. The adaptor proteins Shc, Grb2 and Sos facilitate this signaling mechanism which leads to activation of ras and raf proteins. Downstream events involve (a) members of the MEK kinases that lead to activation of ERK proteins, (b) the p38 kinase pathway and (c) the JNK/SAP pathway. There is evidence of overlap among the above mentioned three downstream cascades which culminate in activation of c-fos, c-jun and c-myc gene transcription Figure 5 The PI-3K signal transduction pathway. Src kinases mediate their signals via the PI-3K pathway. Adaptor proteins, such as Shc, Grb2 and Cbl, also may be in complex with Srckinases that activate the PI-3K pathway. PI-3K mediates its signals via the PKB/AKT proteins which results in activation of c-fos, c-jun and c-myc gene transcription IL-3 signaling and JAK-Src-STAT pathway EP Reddy et al 850 amino acids long and are characterized by the presence of a DNA-binding domain followed by putative SH3 and SH2 domains (Figure 6 ; Darnell, 1997). In addition, alternative splicing or posttranslational proteolytic cleavage reactions appear to generate additional forms for STAT-1, 3 and 5, bringing the total number of STATs currently described in literature to 10 ( Figure 6 ). Dierentially spliced STATs such as STAT 1b, lacking the Cterminal TA domain can still bind DNA but do not activate transcription (Darnell, 1997) . Thus, two isoforms of STAT1 have been described, which have been termed as STAT1a or p91 and STAT 1b or p84. These two proteins were originally discovered by Darnell's group in association with STAT-2 and a fourth protein termed p48, which constituted the multicomponent transcription factor ISGF3 (Darnell et al., 1994) . STAT-3 also exists in two forms termed STAT3a and STAT3b with dierent transcriptional activation functions (Schaefer et al., 1995; Chaturvedi et al., 1997 Chaturvedi et al., , 1998 . STAT5 exists in two isoforms, termed as STAT5A and STAT5B (Mui et al., 1995a,b) , which are encoded by two separate genes, which are tandemly linked on human chromosome 17 and mouse chromosome 11 (Lin et al., 1996; Copeland et al., 1995) . The two proteins exhibit extensive sequence homology and dier from each other mainly in the amino and carboxy terminal domains, with the transactivation domain showing most divergence. Both of these genes seem to play a critical role in IL3/IL-5/ GMCSF-induced proliferation of hematopoietic cells as well as prolactin-induced mammary epithelial cell proliferation Quelle et al., 1994; Cornelis et al., 1995; Matsuguchi et al., 1997; Itoh et al., 1996) . Like most transcription factors, STATs exhibit a modular structure with ®ve well de®ned domains, which include the N-terminal conserved domain, the DNA-binding domain, a putative SH3-like domain, a SH2 domain and C-terminal transactivation domain (Figure 6 ). The amino terminal region of STATs is well conserved and appears to be critical for STAT function as small deletions in this region were found to eliminate the ability of STATs to be phosphorylated. This region is followed by the DNA binding domain, which is usually located between amino acids 400 and 500 (Horvath et al., 1995) . This region is highly conserved amongst the STATs, and all STATs with the exception of STAT-2 dierentially bind more than 10 related GAS sequences that are characterized by the consensus sequence motif, TTNCNNNAA (Horvath et al., 1995; Xu et al., 1996) . Adjacent to the DNA binding domain lies the putative SH3 domain. This domain appears to be least conserved Figure 6 STAT protein structure. Cytokines signal via members of the STAT family of proteins. The various STAT proteins, many of which are derived upon alternative splicing events (eg: Stat 1, Stat 3, Stat 4 and Stat 5) comprise of approximately 800 amino acid residues. Sequence analysis indicates that the STAT proteins harbor conserved motifs, such as the DNA binding region (DNAB), SH2 and SH3 domains that allow DNA-protein and protein-protein interactions. The transactivation (TA) domain and the highly conserved phosphorylatable tyrosine (pY) and serine (pS) residues that are essential for optimal STAT activation reside at the carboxy terminus of the proteins and it is at present unclear as to whether it truly functions as a SH3 domain since the critical amino acid residues involved in binding to PXXP motifs do not appear to be well conserved. Adjacent to this putative SH3 domain lies the SH2 domain, which is highly conserved amongst the STATs and appears to play a very important role in STAT signaling. Thus, it is critical for the recruitment of STATs to the activated receptor complexes and is required for the interaction with JAK and Src kinases. In addition, it is required for STAT homo-and hetero-dimerization, which in turn appears to be critical for nuclear localization and DNA binding activities (Darnell, 1997) . It is also possible that this domain participates in other protein-protein interactions that have not yet been fully deciphered. Immediately downstream of the SH2 domain, around position 700, all STATs contain a tyrosine residue, which plays a critical role in STAT activation. Phosphorylation of this tyrosine residue has been found to be essential for the activation and dimerization of STATs Darnell, 1997) . Phosphorylation of this tyrosine appears to be achieved by growth factor receptors as well as JAK and Src kinases, depending on the nature of the cell type and the ligand/receptor interactions. The C-terminal domain of STATs is required for transcriptional transactivation. Phosphorylation of a single serine residue in the TA domains of STAT1, STAT3, STAT4 and STAT5, by MAP kinases can enhance the transcriptional activity (Zhang et al., 1995; Wen et al., 1995; David et al., 1995; Ihle, 1996) .
STATs, which are normally localized in the cytoplasm are activated when phosphorylated on the tyrosine located around residue 700, which facilitates their dimerization and translocation to the nucleus (Darnell et al., 1994; Schindler and Darnell, 1995) . The phosphorylation of STATs is known to occur immediately after the binding of growth factors or interferons to their receptors. Studies with interferon (IFN) receptor signaling have revealed that JAK family kinases are involved in IFN-speci®c gene expression in cooperation with STATs (Darnell et al., 1994; Schindler and Darnell, 1995) . Studies with mutant cell lines, which were unable to respond to interferons, were used to dissect the interferon signaling pathways Watling et al., 1993) . In one set of studies, a mutant cell line designated as U1 was used which failed to respond to IFN-a or IFN-b but remained responsive to IFNg. Transfection of TYK2 was found to restore the interferon-a/b response of this cell line. Another set of mutants, the g mutants, failed to respond to IFN-g, but retained their IFNa/b responsiveness. Ectopic expression of JAK2, but not TYK-2 or JAK-1 in these cells resulted in the restoration of cellular response to IFN-g (Watling et al., 1993) . Studies with U4 mutant cell line , which was unable to respond to either IFN-a/b or g revealed that it had a truncated JAK1 transcript and introduction of JAK1 expression constructs into these cells resulted in restoration of the IFN-a/b and g response. These studies, in combination with other studies revealed that JAK1 and TYK2 are required for IFN-a/b response whereas JAK1 and JAK2 are essential for IFN-g response.
Since the cytokine and interferon receptor-ligand interactions were found to result in the activation of JAK kinases, which often exist in association with cytokine receptors, and this activation was obligatory for the activation of STATs, it was proposed that STATs might be substrates for JAK kinases. This notion was further supported by studies which showed in vitro phosphorylation of puri®ed STAT-5 by JAK-2 (Flores-Morales et al., 1998). In this study, the investigators expressed STAT-5 in Sf9 insect cells using the baculovirus expression system and showed that this recombinant protein can be phosphorylated by JAK-2, which confers DNA binding property to STAT-5. In addition, these investigators showed STAT-5 in its non-phosphorylated form was able to form a stable complex with activated JAK2, while non-activated JAK2 and phosphorylated STAT-5 were unable to participate in complex formation. A second line of evidence, which suggested that JAKs might be activators of STATs, came from the use of dominant negative mutants. Over-expression of dominant negative JAK1 and TYK2 mutants into human cells suppressed transcriptional activation of a luciferase reporter gene downstream from an ISRE. In addition, these dominant negative mutants were found to inhibit STAT-1 and STAT-2 phosphorylation (Krishnan et al., 1997) .
However, the activated JAK kinases do not seem to exhibit speci®city for a particular STAT as dierent receptors activate a common STAT, even though they activate distinctly dierent JAK kinases (Kohlhuber et al., 1997; Darnell, 1997) . In addition chimeric receptor molecules with dierent JAK binding sites but containing the same STAT-binding site were found to activate the same STAT (Kotenko et al., 1996; Kohlhuber et al., 1997) . Thus, the speci®city for STAT phosphorylation appears to be determined by the docking sites for STATs that are present in the receptor molecules and not JAK kinases.
Src-tyrosine kinases and STAT proteins: a covert liaison Interaction of IL-3 with its receptor has been shown to activate multiple STATs, which include STAT-1, STAT-3, STAT-5 and STAT-6. However, the nature of STATs activated seem to depend on the cell type that is being studied rather than on the nature of JAK activated or the nature of STATs expressed in these cell lines, as all of them seemed to express these STATs Azam et al., 1995; Mui et al., 1996; Chaturvedi et al., 1997 Chaturvedi et al., , 1998 . The two isoforms of STAT5, STAT5a and STAT5b as well as STAT6 are activated by receptors for IL-3, GM-CSF and IL-5 Azam et al., 1995) . IL-3 stimulation leads to activation of JAK2 and phosphorylation and activation of STAT5a (via tyrosine phosphorylation of Y694) and STAT5b (via tyrosine phosphorylation of Y699). Mutational studies with the IL-3, GM-CSF and IL-5 receptors have shown that JAK2 is essential for STAT activation (Kouro et al., 1996; Matsuguchi et al., 1997; Caldenhoven et al., 1995; Mui et al., 1995a,b; Smith et al., 1997) . However, a C-terminal mutant of the b c chain has been described that can activate JAK2 but is unable to activate STAT5 indicating that activation of JAK2 is not sucient for STAT5 activation (Smith et al., 1997) . Several studies highlight the importance of STAT activation in proliferation induced by the IL-3, GM-CSF IL-3 signaling and JAK-Src-STAT pathway EP Reddy et al and IL-5 receptors. Mutations in the a or b c chains of these receptors, that result in loss of STAT activation, lead to defects in proliferation Quelle et al., 1994; Cornelis et al., 1995; Matsuguchi et al., 1997; Itoh et al., 1996) . Also, it has been observed that IL-3-dependent growth is suppressed in BaF3 cells that express dominant negative STAT5 proteins (Mui et al., 1996) . The IL-3 response mediated by STAT5 may be processed by STAT5 target genes, including c-fos, pim-1 and oncostatin (Mui et al., 1996; Wang et al., 1996; Yoshimura et al., 1996) . A role for Src kinases in STAT activation was ®rst suggested by studies aimed at investigating the molecular mechanisms associated with Src-mediated transformation of ®broblasts and hematopoietic cell lines. Thus Src-transformed NIH3T3 cells were found to express a tyrosine phosphorylated form of STAT-3 in a constitutive manner (Yu et al., 1995; Cao et al., 1996) . In addition, results from Cao et al. (1996) showed that v-Src can bind to STAT-3 and phosphorylate this protein in vitro. Transfection of an expression vector coding for a dominant negative mutant of STAT-3 into v-Src-transformed NIH3T3 cells resulted in a block to v-Src-mediated transformation of cells, further enforcing the notion that STAT-3 signaling plays a critical role in this transformation process (Liu et al., 1998; Smith and Crompton, 1998; Bromberg et al., 1998; Cao et al., 1996; Turkson et al., 1998) .
In our studies aimed at delineating the molecular mechanisms associated with v-Src-mediated transformation of hematopoietic cells, we used 32Dcl3 cells that are derived from normal mouse bone marrow and require IL-3 for proliferation and survival. These cells, when cultured in the presence of G-CSF were found to terminally dierentiate into mature granulocytes in a period of 10 ± 12 days . When these cells were grown in a medium lacking IL-3 or G-CSF, they were found to undergo apoptosis in a period of 24 ± 48 h. This cell line, when transformed with expression vectors containing v-abl or bcr-abl or v-src was found to grow inde®nitely in the absence of IL-3 and to form tumors in nude mouse assays (Kruger and Anderson, 1991; Laneuville et al., 1991; Rovera et al., 1987) . In addition, expression of either v-src, v-abl or bcr-abl was found to block the ability of 32Dcl3 cells to undergo GCSF-induced dierentiation Laneuville et al., 1991) . Interestingly, several other tyrosine kinases closely related to v-src failed to induce such cytokineindependence of these cells suggesting a very speci®c target for v-Src in these cells. Thus, when v-fgr or an activated form of c-fgr which lacks the C-terminal 12 amino acids (c-fgrd) were expressed in this cell line, they failed to render these cells IL-3-independent for growth (Chaturvedi et al., 1997) . Since fgr and src genes share extensive homology in their SH2, SH3, and tyrosine kinase domains (King and Cole, 1990; Naharro et al., 1984) , this observation oered us a very convenient method to test the structural domains required for v-srcmediated eects on 32Dcl3 cells. To address this speci®c issue we took advantage of the close structural relationship between v-src and v-fgr genes and constructed chimeras where the tyrosine kinase and SH2 or SH3 domains of these two genes have been interchanged. Transfection of these chimeras into 32Dcl3 cells was performed and the ability of dierent chimeric proteins to transform 32Dcl3 cells was assessed by determining their ability to grow in the absence of IL-3. These studies showed that only those chimeras containing both the SH3 and SH2 domains of v-Src were capable of transforming the 32Dcl3 cell line such that it could grow in the absence of IL-3.
To understand the possible mechanisms underlying the IL-3-independent growth of v-src-transformed 32Dcl3 cells, we examined the phosphorylation status of JAK-1, JAK-2 and JAK-3 kinases in the v-src and v-fgr-transformed cells. These studies showed that none of the JAK kinases were phosphorylated by v-Src or vFgr. However, v-src-transformed cells were found to express constitutively phosphorylated forms of STAT-1,3 and 5, which exhibited appropriate DNA binding activities. Our results also showed that STAT-3 coimmunoprecipitates with v-Src, suggesting that the activation of STAT-3 occurs due to direct association with v-Src. Since hematopoietic cells express high levels of c-Src and since Src kinases associate with IL-3 receptor following its activation by IL-3, this observation suggested that c-Src might play a role in the activation of STAT-3 in normal hematopoietic cells following IL-3 stimulation.
To examine the role of c-Src in IL-3-mediated activation of myeloid cell proliferation, we examined the phosphorylation status of JAKs and STAT-3 in 32Dcl3 cells following IL-3 stimulation (Chaturvedi et al., 1998) . These studies showed that IL-3 stimulation induces rapid tyrosine phosphorylation of JAK-1 and JAK-2 in 32Dcl3 cells. In addition, our results showed that interaction of IL-3 with its receptor leads to the phosphorylation and nuclear translocation of STAT-1, STAT-3 and STAT-5. In addition, this ligand/receptor interaction leads to the activation of c-Src kinase activity, which in turn facilitates the binding of c-Src to STAT-3. This association leads to the phosphorylation of STAT-3, allowing this transcription factor to translocate to the nucleus. Expression of a dominant negative mutant of src (AMSrc) in these cells results in a block to IL-3-mediated phosphorylation of STAT-3, and its ability to bind to DNA. On the other hand, expression of a dominant negative mutant of JAK2 (JAK2KE) had no eect on IL-3-mediated activation of STAT-3. Our results also show that AMSrc does not aect the phosphorylation of JAK2, suggesting that JAK and STAT-3 phosphorylation events are mediated by two independent pathways. Inhibition of c-Src activation by AMSrc, which leads to a block to STAT-3 activation, results in a dramatic inhibition of cell proliferation mediated by IL-3. However, expression of AMSrc does not activate apoptotic pathways. In contrast, expression of JAK2KE results in accelerated apoptosis of 32Dcl3 cells grown in the absence of IL-3 with concomitant down-regulation of Erk-2 kinase activity. These results suggest that Src family kinases mediate the phosphorylation of STAT-3 mediated by IL3/receptor interactions and play a critical role in signal transduction pathways associated with myeloid cell proliferation. These results also suggest that activation of STAT-3 following cytokine stimulation of hematopoietic cells might follow a very dierent pathway from that seen with STAT-5. These results taken together indicate that while one or both isoforms of STAT-5 interact directly with JAK-2, which in turn mediates their phosphorylation, STAT-3 activation might require its interaction with c-Src, which in turn mediates its phosphorylation. Based on these results, we propose a JAK-Src-STAT model, where JAK kinases may be more crucial to phosphorylation of the cytokine/growth factor receptors and in the process create docking sites on the receptors for binding of SH2-containing proteins such as STATs, Src-kinases and other signaling intermediates. Tyrosine phosphorylation and activation of STAT proteins is then achieved either by JAKs or Src-kinases depending on the nature of STAT that is being activated (Figure  7) .
The notion that dierent STATs might be phosphorylated by dierent tyrosine kinases under dierent conditions is suggested by two other observations. Like v-Src, v-Abl and BCR-ABL have been shown to transform hematopoietic cells and render them cytokine-independent for growth (Pierce et al., 1985; Cook et al., 1985; Mathey-Prevot et al., 1986) . Thus, v-Abl encoded by the Abelson Murine Leukemia Virus was found to transform both B cells and myeloid cells resulting in cytokine-independent growth of these cells (Pierce et al., 1985; Cook et al., 1985; Mathey-Prevot et al., 1986) . Examination of the molecular mechanisms associated with v-Abl-mediated transformation show that B cells transformed by this oncogene exhibit constitutively activated forms of JAK-1, JAK-3 as well as STAT-1, 3 and 5 (Danial et al., 1995 (Danial et al., , 1998 In sharp contrast, the BCR-ABL oncogene, a gene closely related to the v-Abl oncogene was found to constitutively activate STAT-1 and STAT-5 with very little or no activation of JAKs (Carlesso et al., 1996; Ilaria et al., 1996; Frank and Varticovski, 1996; Niebrowska-Skorska et al., 1999) . Unlike with v-Abltransformed B cells, over-expression of dominant negative JAK kinase mutants in these cell lines had no eect on STAT phosphorylation (Ilaria et al., 1996) . Similarly, K562 cells, which are Philadelphia-chromosome positive, express constitutively activated BCR-ABL and STAT-5 and over-expression of a dominant negative STAT-5 could suppress the transformed state of these cells. Activation of STATs by the BCR-ABL oncogene was shown to be dependent on the presence of the SH2 and SH3 domains (Niebrowska-Skorska et al., 1999) , suggesting a Src-like interaction reported by us (Chaturvedi et al., 1998) . These observations would also provide a molecular basis for the inability of v-Abl to directly activate STATs, since this oncoprotein lacks the SH3 domain that is present in the BCR-ABL oncogene (Reddy et al., 1983) .
A second line of evidence comes from the study of Kazansky et al. (1999) who studied the DNA-binding and tyrosine phosphorylation of STAT-5A and STAT-5B following prolactin activation or Src activation. Their results show that following prolactin activation, both STAT5A and STAT5B were rapidly phosphorylated and translocated to the nucleus. Similar to prolactin activation, Src activation resulted in tyrosine phosphorylation and DNA binding of both STAT5A and STAT5B. Furthermore, overexpression of a dominant negative mutant of JAK-2 prevented prolactin-induced tyrosine phosphorylation and nuclear translocation of STAT5A and STAT5B. In sharp contrast, over-expression of dominant negative JAK-2 had no eect on Srcmediated phosphorylation of STATs. In fact, there was a modest increase in the levels of Src-mediated phosphorylation of STAT5 in the presence of dominant JAK-2. These studies again suggest that there exist two independent pathways that mediate STAT activation, one that is dependent on JAKs and one that is dependent on Src kinases. The context of the cytokine and cell type appears to play a critical role in determining which pathway is utilized by the cell.
Shc-Ras-MAP kinase pathway
In addition to the activation of STATs, IL-3 as well as a number of other cytokines activate multiple signal transduction pathways, which include the Ras and PI3 kinase pathways. A brief description of these pathways is given below.
Upon IL-3 stimulation, the adaptor molecule Shc is rapidly phosphorylated and associates with the phosphorylated b c subunit of IL-3 (Sato et al., 1993; Pelicci et al., 1992; Blaikie et al., 1994) . IL-3 stimulation also results in tyrosine phosphorylation of the inositol phosphatase (SHIP) which forms a complex with Shc, Grb2 and Sos, which are members of the Ras pathway (Lioubin et al., 1996) . Upon recruitment, Shc binds to the phosphorylated Y577 of the b c subunit and subsequently interacts with the adaptor protein Grb2, which in turn associates with mSos, which is the nucleotide exchange factor for Ras (Pratt et al., 1996; Rozakis-Adcock et al., 1993) . This is followed by the activation of Ras and c-Raf (Pazdrak et al., 1995; Coer et al., 1998a,b; Satoh et al., 1991) . The activation of Ras and c-Raf results in downstream activation of ERK1 and ERK2 that are members of the MAP kinase family (Pazdrak et al., 1995; Raines et al., 1992; Okuda et al., 1992; Welham et al., 1992; Coer et al., 1998a,b) . Activation of this cascade culminates in the increased expression of transcription factors c-fos and c-jun (Itoh et al., 1996; Satoh et al., 1991 Satoh et al., , 1993 .
STAT proteins also serve as substrates for MAP kinases. The C-terminal domain of STATs that is required for transcriptional transactivation harbors a conserved serine residue. Phosphorylation of this serine residue in the TA domains of STAT1, STAT3, STAT4 and STAT5, by MAP kinases can enhance the transcriptional activity of STATs (Zhang et al., 1995; Wen et al., 1995; David et al., 1995; Ihle, 1996) .
In addition to activation of MAP kinase family members ERK1 and ERK2, IL-3 also activates another MAP kinase family member, p38 (Nagata et al., 1997a) . Other members of the MAP kinase family that are activated by the IL-3/IL-5 and GM-CSF cytokines are the JNK/SAPK kinase proteins Terada et al., 1997; Nagata et al., 1997b; Foltz and Schrader, 1997; Liu et al., 1997) . It has been proposed that SEK-1 may be involved in the activation of the JNK/SAPK pathway since IL-3 stimulation results in phosphorylation of SEK-1, at least in MC/9 cells (Foltz and Schrader, 1997) . However, SEK-1 activation was not observed upon IL-3 stimulation of the myeloid cell line FD-CP2 (Nagata et al., 1997b ). The precise mechanism of activation of these kinases is not entirely clear but there is evidence for the involvement of both the a and b c chains of these receptors, speci®cally the importance of Y577 of the b c chain and the kinase JAK2 Terada et al., 1997; Liu et al., 1997) .
PI3K-PKB/AKT pathway
The IL-3/IL-5 and GM-CSF cytokines induce a rapid activation of the lipid kinase phosphatidylinositol-3 kinase (PI3K) (Sato et al., 1993 Coer et al., 1998a,b; Corey et al., 1993; Gold et al., 1994; al Shami et al., 1997) . Interestingly, the same region of the b c chain that is responsible for the activation of the Ras pathway seems to be involved in signaling via the PI3K pathway (Sato et al., 1993) . PI3K associates with the b c chain and this interaction may be in¯uenced by the adaptor protein p80. The p80 adaptor protein acts as a scaold that interacts with the b c chain and the p85 subunit of PI3 kinase in IL-3 stimulated cells (Rao and Mufson, 1995; Jucker and Feldman, 1995) . This scaold complex also contains members of the Src-kinase family, Yes and Lyn (Corey et al., 1993; Jucker and Feldman, 1995; Torigoe et al., 1992) . Downstream proteins recruited by the PI3 kinase pathways upon IL-3 stimulation include the PKB/ AKT protein. PI3K-dependent activation of PKB/AKT in response to IL-3 stimulation has been observed in multiple cell lines and these studies suggest a role for this pathway in the transmission of cell survival signals in response to IL-3 (Coer et al., 1998b; Tilton et al., 1997; Songyang et al., 1997; del Peso et al., 1997) . Another downstream protein activated in response to IL-3 stimulation is p70S6 kinase which also seems to mediate its eects via interaction with the b c chain (Sato et al., 1993; Calvo et al., 1994) . Another protein that feeds into the PI3K-PKB/AKT pathway is the Cbl protein, which also docks onto the adaptor protein Grb2 and Shc. Tyrosine phosphorylation of Cbl has been observed in IL-3-and GM-CSF-stimulated cells which leads to activation of the PI3K pathway (Odai et al., 1995; Anderson et al., 1997; Barber et al., 1997; Chin et al., 1997; Sattler et al., 1996) .
Anti-apoptotic pathways
One of the major phenotypic eects of IL-3 stimulation is its anti-apoptosis or cell survival function. All of the aforementioned pathways, the JAK/STAT pathway, the Shc-Ras-MAPK pathway and the PI3K-PKB/AKT pathways seem to play roles in this key function attributed to IL-3. Thus, overexpression of activated Ras (Ras-Val12) can abrogate the defects in IL-3 signaling and lead to cell survival emphasizing the importance of the Ras pathways in cell survival (Nicola et al., 1996; Terada et al., 1995) . Also, apoptosis induced upon IL-3 withdrawal of 32Dcl3 and BaF3 cells can be overcome by overexpression of oncogenic c-Raf (Cleveland et al., 1994; Kinoshita et al., 1997) . Similarly, expression of a dominant negative MAP kinase (MAPK), which leads to loss of ERK activity, results in defects in IL-3-dependent growth and survival of BaF3 cells (Perkins et al., 1996) .
The Bcl-2 gene family seems to mediate the cell survival or anti-apoptosis function of IL-3. In agreement with this, expression levels of Bcl-2 and Bcl-X L are rapidly induced by IL-3, which seems to depend on Jak2 activation (Kinoshita et al., 1995a,b; Leverrier et al., 1997; Rinaudo et al., 1995; Sakai et al., 1997) . Also, overexpression of Bcl-2 or A1, a homolog of Bcl2, protects IL-3-dependent cells from apoptosis induced upon IL-3 withdrawal (Lin et al., 1996; Ito et al., 1997; Bay et al., 1993) . Several studies indicate that Rasindependent pathways also operate to bring about cell survival in response to IL-3. The PI3K-PKB/AKT pathway also plays a role in the anti-apoptosis function of IL-3. Overexpression of PKB/AKT, which leads to increased expression of c-myc, Bcl-2 and the Bcl-2 family member BAD, protects 32Dcl3 and BaF3 cells from IL-3 withdrawal-mediated apoptosis whereas expression of non-functional PKB/AKT acclerates apoptosis due to IL-3 withdrawal (Songyang et al., 1997; del Peso et al., 1997; Ahmed et al., 1997; Datta et al., 1997) .
Conclusions
It is becoming increasingly clear that the interaction of cytokines with their receptors leads to the activation of multiple signal transduction pathways, which are very similar for several cytokines. However, each cytokine appears to elicit dierent biochemical and biological responses from a given cell. These responses appear to be dierent for dierent cytokines, even when they share the same signal transducing receptor unit. This becomes very apparent when one examines the nature of the biological response elicited by IL-3 and GMCSF, both of which share the same b-chain. It is therefore reasonable to assume that dierent cytokines elicit a dierent combination of responses and these responses are dependent on the nature of their receptor components (such as the alpha chains) as well as the nature of cellular factors that are present in a given cell type. The nature of the downstream signaling proteins recruited by these receptors account for the functional pleiotropy as well as redundancy of cytokine stimulus. A complete understanding of the subtle dierences that exist between dierent cytokine responses and the cross talk between dierent members of these signal transduction pathways will provide a better understanding of the mechanisms that are involved in the regulation of cell growth, dierentiation and survival.
